What Should the IDEAL HIV self-test look like? A usability study of test prototypes in unsupervised HIV self-testing in Kenya, Malawi, and South Africa

AIDS and Behavior

Volumn 18, Issue SUPPL. 4, 2014, Pages

  Peck, Roger B ^a   Lim, Jeanette M ^a   Van Rooyen, Heidi ^e   Mukoma, Wanjiru ^c   Chepuka, Lignet ^d   Bansil, Pooja ^a   Knight, Lucia C ^f   Muturi, Nelly ^c   Chirwa, Ellen ^d   Lee, Arthur M ^a   Wellhausen, Jeff D ^a   Tulloch, Olivia ^b   Taegtmeyer, Miriam ^b  

^a PATH   (United States)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c Liverpool VCT   (Kenya)

^d Kazumu College of Nursing   (Malawi)

^e HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^f UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

HIV self test; Prototypes; Sub Saharan Africa; Target product profile; Usability

Indexed keywords

ADULT; ARTICLE; DIAGNOSTIC KIT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MALAWI; MALE; MASS SCREENING; METHODOLOGY; PATIENT ATTITUDE; SELF CARE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SOUTH AFRICA; UTILIZATION REVIEW;

ADULT; AIDS SERODIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; KENYA; MALAWI; MALE; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; REAGENT KITS, DIAGNOSTIC; SELF CARE; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA;

EID: 84904406804     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-014-0818-8     Document Type: Article

References (23)

1. World Health Organization. Report on the first international symposium on self-testing for HIV: the legal, ethical, gender, human rights and public health implications of self-testing scale-up. Geneva: World Health Organization; 2013.
2. Pant Pai N, Sharma J, Shivkumar S, Pillay S, Vadnais C, Joseph L, et al. Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review. PLoS Med. 2013;10(4):e1001414.
3. Krause J, Subklew-Sehume F, Kenyon C, Colebunders R. Acceptability of HIV self-testing: a systematic literature review. BMC Public Health. 2013;13:735.
4. Gaydos CA, Hsieh YH, Harvey L, Burah A, Won H, Jett-Goheen M, et al. Will patients "opt in" to perform their own rapid HIV test in the emergency department? Ann Emerg Med. 2011;58(1 Suppl 1):S74-8.
5. Ibitoye M, Frasca T, Giguere R, Carballo-Dieguez A. Home testing past, present and future: lessons learned and implications for HIV home tests. AIDS Behav. 2014;18(5):933-49.
6. Lee VJ, Tan SC, Earnest A, Seong PS, Tan HH, Leo YS. User acceptability and feasibility of self-testing with HIV rapid tests. J Acquir Immune Defic Syndr. 2007;45(4):449-53. (Pubitemid 47057673)
7. de la Fuente L, Rosales-Statkus ME, Hoyos J, Pulido J, Santos S, Bravo MJ, et al. Are participants in a street-based HIV testing program able to perform their own rapid test and interpret the results? PLoS One. 2012;7(10):e46555.
8. Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, et al. The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 2011;8(10):e1001102.
9. United States Food and Drug Administration. Testing for HIV. USFDA website 2012. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ ucm080466.htm. Accessed 16 June 2014.
10. Draft Guidance for Industry and Food and Drug Administration Staff. Applying Human Factors and Usability Engineering to Optimize Medical Device Design. USFDA website 2011 June 22. http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm259748.htm. Accessed 16 June 2014.
11. MaRS Entrepreneur Workbooks Defining your target product profile. MaRS 2011. http://www.marsdd.com/app/uploads/2011/03/Defining-Your-Target-Product- Profile-In-Vitro-Diagnostic-Products.pdf. Accessed 16 June 2014.
12. Mabey D, Peeling RW, Ustianowski A, Perkins MD. Diagnostics for the developing world. Nat Rev Microbiol. 2004;2(3):231-40. (Pubitemid 39490084)
13. Rubin J, Chisnell D. Handbook of usability testing. 2nd ed. Indianapolis: Wiley; 2008.
14. Faulkner L. Beyond the five-user assumption: benefits of increased sample sizes in usability testing. Behav Res Methods Instrum Comput. 2003;35(3):379-83. (Pubitemid 37545007)
15. Bahl R, Murphy DJ, Strachan B. Qualitative analysis by interviews and video recordings to establish the components of a skilled low-cavity non-rotational vacuum delivery. BJOG. 2009;116(2):319-26.
16. Schaeffer JH. Videotape: new techniques of observation and analysis in anthropology. In: Hockings P, editor. Principles of visual anthropology. 2nd ed. The Hague: Mouton de Gruyter; 1995. p. 255.
17. Sankar A, Golin C, Simoni JM, Luborsky M, Pearson C. How qualitative methods contribute to understanding combination antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2006;1(43 Suppl 1):S54-68. (Pubitemid 44885643)
18. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. London: Routeledge; 1996.
19. Gillet P, Scheirlinck A, Stokx J, De WA, Chauque HS, Canhanga OD, et al. Prozone in malaria rapid diagnostics tests: how many cases are missed? Malar J. 2011;10:166.
20. Anderson DA, Crowe SM, Garcia M. Point-of-care testing. Curr HIV/AIDS Rep. 2011;8(1):31-7.
21. Spielberg F, Levine RO, Weaver M. Self-testing for HIV: a new option for HIV prevention? Lancet Infect Dis. 2004;4(10):640-6. (Pubitemid 39296839)
22. Luchavez J, Lintag ME, Coll-Black M, Baik F, Bell D. An assessment of various blood collection and transfer methods used for malaria rapid diagnostic tests. Malar J. 2007;6:149.
23. Strategic Evaluation, Advisory and Development Consulting. Analysis of POCT/VCT Performed at South African Primary Health Care Clinics. Strategic, Evaluation, Advisory & Development (SEAD) Consulting website 2013. www.sead.co.za/downloads/POCT-clinics-2011.pdf. Accessed 16 June 2014.